Clinical Trial

Transcriptional Framework for the Molecular Diagnosis of Response to Immunotherapy in Lung Cancer With Agnostic Potential

Study acronym: KEAPnes
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 4, 2025 (before its estimated June 4, 2026 completion). Its status may not reflect the trial's current state.
Summary
Through genomic and transcriptomic sequencing techniques (whole exome sequencing, WES; whole transcriptome sequencing, WTS) patients with enrichment for KEAPness and specific gene interactions associated with it.
Trial Details
NCT Number NCT06807307
Lead Sponsor Regina Elena Cancer Institute
Conditions NSCLC
Enrollment 256 participants
Start Date 2024-06-04
Primary Completion 2026-06-04 (estimated)
Study Completion 2026-06-04 (estimated)
Updated on ClinicalTrials.gov 2025-02-04